Frontiers in Oncology (Nov 2024)

Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report

  • Suli Chen,
  • Yanjun Lin,
  • Shuncai Gao,
  • Shuo Liu,
  • Zhanmin Yang,
  • Ruiqing Ma,
  • Liangyuan Lu

DOI
https://doi.org/10.3389/fonc.2024.1449171
Journal volume & issue
Vol. 14

Abstract

Read online

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a leading treatment for advanced ovarian cancer, significantly improving overall survival and disease-free survival. This case involves a patient with peritoneal metastasis and ultra-high intra-abdominal pressure (36 mmHg). CRS + HIPEC induces extensive pathological and physiological changes affecting respiratory, circulatory, renal, coagulation, and metabolic systems. Effective perioperative anesthesia management, including the type and volume of fluids administered, is crucial for optimizing patient outcomes. The complexities of anesthesia management in such cases present significant challenges.

Keywords